Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Life Sciences Industry Analysis

UpdatedJan 15, 2026
DataAggregated Company Financials
Companies9
  • 7D-2.4%
  • 3M-12.9%
  • 1Y-3.3%
  • YTD0.07%

In the last week, the Life Sciences industry is flat overall, with MedCap standing out by going down 6.2%. Furthermore, the industry has been flat for the past year as well. Earnings are forecast to grow by 26% annually.

Industry Valuation and Performance

Has the Swedish Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 15 Jan 2026SEK 30.2bSEK 14.9b-SEK 744,515,427.0047.9x-40.5x2x
Sat, 13 Dec 2025SEK 32.9bSEK 14.9b-SEK 744,515,427.0054.5x-44.2x2.2x
Mon, 10 Nov 2025SEK 34.5bSEK 14.7b-SEK 748,598,012.0057.3x-46x2.3x
Wed, 08 Oct 2025SEK 35.4bSEK 14.7bSEK 61.3m58.4x578.3x2.4x
Fri, 05 Sep 2025SEK 34.4bSEK 14.7bSEK 60.9m55.5x565.6x2.3x
Sun, 03 Aug 2025SEK 35.8bSEK 14.8bSEK 158.0m61.3x226.3x2.4x
Tue, 01 Jul 2025SEK 46.5bSEK 16.6bSEK 416.3m68.5x111.7x2.8x
Thu, 29 May 2025SEK 45.6bSEK 16.6bSEK 404.2m72.3x112.9x2.7x
Sat, 26 Apr 2025SEK 43.1bSEK 16.6bSEK 580.4m46.5x74.2x2.6x
Mon, 24 Mar 2025SEK 37.2bSEK 16.6bSEK 614.3m38x60.5x2.2x
Wed, 19 Feb 2025SEK 44.0bSEK 17.0b-SEK 1,033,505,426.0043.3x-42.6x2.6x
Fri, 17 Jan 2025SEK 41.8bSEK 16.7b-SEK 1,152,911,426.0043.4x-36.3x2.5x
Sun, 15 Dec 2024SEK 44.1bSEK 16.7b-SEK 1,152,911,426.0050.4x-38.3x2.6x
Tue, 12 Nov 2024SEK 44.7bSEK 16.8b-SEK 948,072,426.0050.9x-47.1x2.7x
Thu, 10 Oct 2024SEK 47.1bSEK 16.7b-SEK 988,175,491.0058.7x-47.7x2.8x
Sat, 07 Sep 2024SEK 47.4bSEK 16.7b-SEK 988,176,492.0059.9x-48x2.8x
Mon, 05 Aug 2024SEK 47.4bSEK 16.7b-SEK 1,128,120,510.0059.9x-42x2.8x
Wed, 03 Jul 2024SEK 42.1bSEK 16.3b-SEK 1,188,686,510.0054.3x-35.4x2.6x
Fri, 31 May 2024SEK 42.3bSEK 16.3b-SEK 1,188,686,510.0059.5x-35.6x2.6x
Sun, 28 Apr 2024SEK 37.7bSEK 16.2b-SEK 1,246,589,705.0036.2x-30.2x2.3x
Tue, 26 Mar 2024SEK 39.7bSEK 16.0b-SEK 1,122,792,210.0034.7x-35.4x2.5x
Thu, 22 Feb 2024SEK 39.3bSEK 16.2b-SEK 1,117,407,350.0043.4x-35.2x2.4x
Sat, 20 Jan 2024SEK 35.8bSEK 15.5b-SEK 1,393,723,683.0042.9x-25.7x2.3x
Mon, 18 Dec 2023SEK 38.2bSEK 15.5b-SEK 1,393,723,683.0047.6x-27.4x2.5x
Wed, 15 Nov 2023SEK 32.6bSEK 15.4b-SEK 1,256,647,710.0037.7x-25.9x2.1x
Fri, 13 Oct 2023SEK 25.2bSEK 15.1b-SEK 1,134,516,711.0035.7x-22.2x1.7x
Sun, 10 Sep 2023SEK 29.2bSEK 15.1b-SEK 1,133,713,072.0038.8x-25.8x1.9x
Tue, 08 Aug 2023SEK 31.9bSEK 15.1b-SEK 213,871,038.0046.3x-149.2x2.1x
Thu, 06 Jul 2023SEK 36.6bSEK 14.6b-SEK 172,476,038.0039x-212.1x2.5x
Sat, 03 Jun 2023SEK 40.0bSEK 14.6b-SEK 173,602,038.0039.5x-230.2x2.7x
Mon, 01 May 2023SEK 36.4bSEK 14.5b-SEK 138,425,792.0035x-262.9x2.5x
Wed, 29 Mar 2023SEK 31.8bSEK 14.6b-SEK 57,185,459.0031.1x-556.2x2.2x
Fri, 24 Feb 2023SEK 38.4bSEK 14.7b-SEK 47,348,929.0030.7x-811.4x2.6x
Sun, 22 Jan 2023SEK 38.7bSEK 14.2bSEK 943.9m38.1x41x2.7x
Price to Earnings Ratio

41x


Total Market Cap: SEK 38.7bTotal Earnings: SEK 943.9mTotal Revenue: SEK 14.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Life Sciences Industry Price to Earnings3Y Average -18.9x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 2.5x is higher than the industry's current PS ratio of 2.0x.
Past Earnings Growth
  • Total earnings for the Life Sciences industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-0.011%
Healthcare0.16%
Life Sciences-2.35%
Clinical Research and Equipment-2.35%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
IDLDX IDL DiagnosticsSEK 0.354.1%
+SEK 3.2m		-24.9%PS1.6x
ATANA AttanaSEK 0.0080%
SEK 2.7m		60.0%PS3.4x
LEVBIO Level BioSEK 0.325.3%
+SEK 1.1m		18.1%PS0.7x

Latest News

ALIF B
SEK 153.20
AddLife
7D
-1.2%
1Y
8.7%

ALIF B: Stable Margins And Refined Discount Rate Will Support Future Upside Potential

Analysts have kept their fair value estimate for AddLife steady at SEK 208.50, with small tweaks to inputs like the discount rate and assumed future P/E reflecting fine tuning of their valuation approach, rather than a fundamental shift in their view of the company. Valuation Changes Fair Value Estimate unchanged at SEK 208.50 per share, indicating no revision to the overall target level.
MAGLE
SEK 15.80
Magle Chemoswed Holding
7D
-8.7%
1Y
-57.3%
IDLDX
SEK 0.35
IDL Diagnostics
7D
4.1%
1Y
-24.9%
MCAP
SEK 522.00
MedCap
7D
-4.6%
1Y
-11.1%
BICO
SEK 18.56
BICO Group
7D
-4.7%
1Y
-39.6%

Little Excitement Around BICO Group AB (publ)'s (STO:BICO) Revenues

Dec 02
Little Excitement Around BICO Group AB (publ)'s (STO:BICO) Revenues
PRO
SEK 14.25
Promimic
7D
-12.8%
1Y
-34.9%
GENO
SEK 21.40
Genovis AB (publ.)
7D
-0.5%
1Y
-14.4%

Genovis AB (publ.)'s (STO:GENO) Weak Earnings May Only Reveal A Part Of The Whole Picture

Nov 15
Genovis AB (publ.)'s (STO:GENO) Weak Earnings May Only Reveal A Part Of The Whole Picture
PEXA B
SEK 0.23
PExA
7D
-1.7%
1Y
-40.4%
ATANA
SEK 0.008
Attana
7D
0%
1Y
60.0%
LEVBIO
SEK 0.32
Level Bio
7D
5.3%
1Y
18.1%